Disseminated breast cancer cells prior to and after high-dose therapy

Journal of Hematotherapy and Stem Cell Research

Volumn 10, Issue 5, 2001, Pages 681-689

  Kruger W H ^a,b   Kroger N ^a   Togel F ^a   Renges, H ^a   Badbaran, A ^a   Hornung, R ^a   Jung, R ^a   Gutensohn, K ^a   Gieseking, F ^a   Janicke F ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; BONE MARROW; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0034779671     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581601753193904     Document Type: Article

References (17)

1. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
2. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
3. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
4. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques
5. High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study
6. Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer
7. Immunomagnetic tumor cell selection-implications for the detection of disseminated cancer cells
8. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients
9. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
10. Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated
11. Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer
12. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors
13. Influence of pre-harvest tumour cell contamination in bone marrow or blood does not predict resultant tumour cell contamination of G-CSF mobilised stem cells
14. Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells
15. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
16. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
17. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer